Search

Your search keyword '"Rando, Ariadna"' showing total 132 results

Search Constraints

Start Over You searched for: Author "Rando, Ariadna" Remove constraint Author: "Rando, Ariadna"
132 results on '"Rando, Ariadna"'

Search Results

2. Molecular characterization and clinical impact of human bocavirus at a tertiary hospital in Barcelona (Catalonia, Spain) during the 2014–2017 seasons

3. Genomic evolution of human respiratory syncytial virus during a decade (2013–2023): bridging the path to monoclonal antibody surveillance

4. HTLV-1-associated myelopathy in Spain

5. Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions

7. Late presentation of human T-lymphotropic virus type 1 infection in Spain reflects suboptimal testing strategies

8. Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

10. Vaccine Safety and Immunogenicity in Patients With Multiple Sclerosis Treated With Natalizumab

11. Assessing the rate of non‐linkage to care and identifying barriers in individuals living with hepatitis B. Results of the LINK‐B study

12. Sophisticated viral quasispecies with a genotype-related pattern of mutations in the hepatitis B X gene of HBeAg-ve chronically infected patients

13. Assessing the rate of non‐linkage to care and identifying barriers in individuals living with hepatitis B. Results of the LINK‐B study.

14. Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions

17. Comparison of Extracellular Vesicle Isolation Methods for miRNA Sequencing

18. Comparison of Extracellular Vesicle Isolation Methods for miRNA Sequencing

20. Specific Plasma MicroRNA Signatures Underlying the Clinical Outcomes of Hepatitis E Virus Infection

21. LINK-B: study protocol of a retrospective and prospective project for identification and linkage to care of people living with hepatitis B in a large health area of Barcelona

22. Molecular characterization and clinical impact of human bocavirus at a tertiary hospital in Barcelona (Catalonia, Spain) during the 2014–2017 seasons

23. The frequency of defective genomes in Omicron differs from that of the Alpha, Beta and Delta variants

25. The slowdown of new infections by human retroviruses has reached a plateau in Spain.

26. Characteristics of 24 SARS-CoV-2-Sequenced Reinfection Cases in a Tertiary Hospital in Spain

27. Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

28. Quasispecies fitness partition to characterize the molecular status of a viral population. Negative effect of early ribavirin discontinuation in a chronically infected HEV Ppatient

29. ACE Score Identifies HBeAg-negative Inactive Carriers at a Single-point Evaluation, Regardless of HBV Genotype

30. Late presentation of human T-lymphotropic virus type 1 infection in Spain reflects suboptimal testing strategies : on behalf of the Human T-lymphotropic Virus (HTLV) Spanish Network

31. A year living with SARS-CoV-2: an epidemiological overview of viral lineage circulation by whole-genome sequencing in Barcelona city (Catalonia, Spain)

32. Study of Quasispecies Complexity and Liver Damage Progression after Liver Transplantation in Hepatitis C Virus Infected Patients

34. Resistance‐associated substitutions after sofosbuvir/velpatasvir/voxilaprevir triple therapy failure

35. Host-dependent editing of SARS-CoV-2 in COVID-19 patients

37. Screening and treatment difficulties of hepatitis C virus infected patients with substance use disorders or dual pathology, despite centralized management in an addiction and dual diagnosis center

38. Silencing HBV expression using LNA gapmers: preliminary data of a new promising strategy

39. Usefulness of dried plasma spots using a plasma separation card for serological diagnosis of chronic hepatitis B and C and reflex viral load testing

40. Analysis of hepatitis B virus quasispecies in circulating viral DNA and RNA: are genotype and complexity different?

41. Naturally occurring SARS-CoV-2 gene deletions close to the spike S1/S2 cleavage site in the viral quasispecies of COVID19 patients

42. Conservation and variability of hepatitis B core at different chronic hepatitis stages

43. A case report

45. Prevalence of Mycoplasma genitalium and macrolide resistance among asymptomatic people visiting a point of care service for rapid STI screening: a cross-sectional study

46. Screening for Zika virus infection in 1057 potentially exposed pregnant women, Catalonia (northeastern Spain)

47. Characterization of hepatitis B virus X gene quasispecies complexity in mono-infection and hepatitis delta virus superinfection

48. SAT-163-HBeAg-negative chronic infection: more complex and conserved quasispecies in Hepatitis B X gene

49. Naturally occurring SARS-CoV-2 gene deletions close to the spike S1/S2 cleavage site in the viral quasispecies of COVID19 patients.

50. Prevalence of and macrolide resistance among asymptomatic people visiting a point of care service for rapid STI screening: a cross-sectional study.

Catalog

Books, media, physical & digital resources